Shares of Biodel Inc. BIOD are higher on the session by 0.92%, trading at $1.645.
Overall put volume is now running at 2.14x the daily average, with 45% of all puts traded being purchases on the offer. 1,672 contracts have traded on the session so far.
Biodel Inc. is a development-stage company. The company is a specialty biopharmaceutical company focused on the development and commercialization of treatments for diabetes.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in